Computational guided approach for drug repurposing against SARS-CoV-2
Open Access
- 1 March 2021
- journal article
- research article
- Published by Future Medicine Ltd in Future Virology
- Vol. 16 (3), 211-243
- https://doi.org/10.2217/fvl-2020-0403
Abstract
Background: In the current SARS-CoV-2 outbreak, drug repositioning emerges as a promising approach to develop efficient therapeutics in comparison to de novo drug development. The present investigation screened 130 US FDA-approved drugs including hypertension, cardiovascular diseases, respiratory tract infections (RTI), antibiotics and antiviral drugs for their inhibitory potential against SARS-CoV-2. Materials & methods: The molecular drug targets against SARS-CoV-2 proteins were determined by the iGEMDOCK computational docking tool. The protein homology models were generated through SWISS Model workspace. The pharmacokinetics of all the ligands was determined by ADMET analysis. Results: The study identified 15 potent drugs exhibiting significant inhibitory potential against SARS-CoV-2. Conclusion: Our investigation has identified possible repurposed drug candidates to improve the current modus operandi of the treatment given to COVID-19 patients.Keywords
This publication has 63 references indexed in Scilit:
- P-glycoprotein Inhibition for Optimal Drug DeliveryDrug Target Insights, 2013
- admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET PropertiesJournal of Chemical Information and Modeling, 2012
- Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and DiseaseInternational Journal of Peptides, 2012
- An Insect Nidovirus Emerging from a Primary Tropical RainforestmBio, 2011
- iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysisBMC Bioinformatics, 2011
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- Seeking Membranes: Positive-Strand RNA Virus Replication ComplexesPLoS Biology, 2008
- Inhibition of Human Immunodeficiency Virus Type 1 Assembly and Release by the Cholesterol-Binding Compound Amphotericin B Methyl Ester: Evidence for Vpu DependenceJournal of Virology, 2008
- Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug DesignJournal of Virology, 2008
- The SWISS-MODEL workspace: a web-based environment for protein structure homology modellingBioinformatics, 2005